ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,711,826 | -26.5% | 116,514 | -15.5% | 0.49% | -47.0% |
| Q4 2022 | $6,411,107 | +0.5% | 137,814 | +12.0% | 0.92% | +6.1% |
| Q3 2022 | $6,381,000 | +35.0% | 123,014 | +23.0% | 0.87% | +17.6% |
| Q2 2022 | $4,727,000 | -67.2% | 100,000 | -50.6% | 0.74% | -60.4% |
| Q1 2022 | $14,413,000 | -39.4% | 202,485 | -36.4% | 1.86% | -22.0% |
| Q4 2021 | $23,801,000 | +129.7% | 318,275 | +74.5% | 2.38% | +47.6% |
| Q3 2021 | $10,362,000 | +1870.0% | 182,400 | +1486.1% | 1.62% | +478.9% |
| Q3 2020 | $526,000 | -8.8% | 11,500 | 0.0% | 0.28% | -15.2% |
| Q2 2020 | $577,000 | +5.9% | 11,500 | +8.5% | 0.33% | -48.1% |
| Q1 2020 | $545,000 | – | 10,600 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |